Market capitalization | $208.10m |
Enterprise Value | $199.27m |
P/E (TTM) P/E ratio | 29.34 |
EV/FCF (TTM) EV/FCF | 15.47 |
EV/Sales (TTM) EV/Sales | 0.94 |
P/S ratio (TTM) P/S ratio | 0.98 |
P/B ratio (TTM) P/B ratio | 6.96 |
Dividend yield | 0.87% |
Last dividend (FY24) | $0.55 |
As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.
2 Analysts have issued a LifeVantage Corporation forecast:
2 Analysts have issued a LifeVantage Corporation forecast:
Dec '24 |
+/-
%
|
||
Revenue | 212 212 |
1%
1%
|
|
Gross Profit | 169 169 |
1%
1%
|
|
EBITDA | 14 14 |
70%
70%
|
EBIT (Operating Income) EBIT | 11 11 |
194%
194%
|
Net Profit | 7.34 7.34 |
148%
148%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
LifeVantage Corp. engages in the identification, research, development, and distribution of advanced nutraceutical dietary supplements and personal care products. It operates through the Americas Region; and Asia/Pacific and Europe Region georaphical segments. The firm's products include Protandim, LifeVantage® Omega+ and ProBio, TrueScience, and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.
Head office | United States |
CEO | Steven Fife |
Employees | 222 |
Founded | 1988 |
Website | www.lifevantage.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.